Answers are grounded in this paper and cite their sources.
Early intervention for high-risk smoldering multiple myeloma (HR-SMM) achieves deep and prolonged responses. It is unclear if beneficial outcomes are due to the treatment of less complex, susceptible disease or inaccuracy in clinical definition of cases entered.
No takes yet. Share an insight, caveat, or question.
Kazandjian et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: